Various approaches to increase efficiency of antitumor therapy by a combination of vaccinotherapy, chemotherapy and surgical excision of primary tumor nodes, and also the comparative analyses of therapeutic and preventive application of antitumoral vaccines were carried out in melanoma experimental model. It was postulated that preventive vaccination is able to prevent tumor incidence by 70 %. The combination of vaccinotherapy and surgical treatment of melanoma increases antimetastatic activity of vaccination by 43 %. We conclude the combined therapy would lead to more effective antitumor response.
The key factor stipulating that GM-CSF-producing vaccines are more immunogenic, is the ability of this cytokine to induce differentiation of earlier predecessor cells in to the most effective "professional" APC -dendrite cells. Under the influence of GM-CSF there are increased levels of IL-1 and TNF production by macrophages and thus local inflammation reaction develops and macrophages are activated, granulocytes and NK, NKT cells are additionally attracted to the injection area [8] . The results of clinical applications of GM-CSFproducing vaccines produced from transfected autologic tumor cells of patients proved that therapy is effective for treatment of human cancer [12] . Positive clinical effects were noted in 25-30% patients with melanoma at stages [3] [4] , that were irresponsive to other chemical therapies employed previously. At the same time antitumor vaccination alone proved to be not as affective for cancer therapy [7, 9, 10] .
In order to increase the effectiveness of vaccinotherapy different immunotherapy modes and methods are employed in appropriate experimental in vivo models [6, 10, 15] .
The application of present day combined chemical therapy allowed to increase treatment efficacy, but survival rates remained unchanged [11] . Introducing immunotherapy methods in the combined therapy contributes to increasing the length of remissions without supporting therapy.
Such drugs as cyclophosphamide, doxorubicin can significantly improve antitumor immunization effect [9, 14] . It is based firstly on the ability of a number a chemotherapy drugs to suppress T-regulatory cells, the withdrawal of which increases response to many antigens including those of tumor origin.
Immunotherapy by GM-CSF-producing vaccine in combination with cyclophosphamide and doxorubicin has been employed clinically since 2003 [10, 13] .
Stable remission after surgical treatment of initial tumor node at early stages can be achieved in 80-90% patients. On the other hand, standard surgical removal of local invasive skin melanoma does not guarantee a long disease-free period without relapse (the absence of local exacerbation and distant metastasis).
For late stages of the disease, usually, it is necessary to combine different kinds of therapy, i.e. immunotherapy, chemical therapy and surgical treatment [2] . The cells express a number of tumor specific antigens and particularly express low levels or none of the MHC. For the vaccinotherapy BG melanoma B16F10 GM-CSF-producing clones were used.
They were exposed to γ-rays by Agat-R using 60 Co at the experimental therapy clinic of the N.N.
Blokhin Russian Cancer Research Center. The irradiation dose was 100 gray.
Antitumor effect was evaluated based on by tumour growth retardation and mice survival dynamics. Antimetastatic effects were evaluated by weight and metastatic colony number in lungs according to standard techniques. Surgical operations were performed using gexanal anesthesia (100 mg/kg one time intra abdominal).
RESALTS AND DISCUSSIONS.
With In order to induce tumors mice were transplanted subcutaneously with 10 5 B16F10 cells.
During the vaccination every mouse was injected subcutaneously with 1x10 6 of antitumor whole cell GM-CSF-producing vaccine.
The dynamics of tumor growth in a typical experiment is shown in table 1. In the course of experiments appearance of infiltrates was noted at the place of injection, which disappeared by the end of the experiments. This process reflects the induction of the immune reaction at the place of injection, which can be described as delayed-type hypersensitivity reaction, and degree of its expression [4] . This statement is supported by the data provided in table 2, which shows the same lifespan for the control group and the group that has received vaccination. The vaccinotherapy also inhibited metastatic process of melanoma B16F10 by 29-43% using surgical excision of the initial tumor node (for various schedules of vaccination).
The most effective was schedule of vaccination before and after the surgical excision of the initial tumor node.
For biotherapy every mouse was injected with 1x10 6 antitumor cell-whole GM-CSFproducing vaccine cells subcutaneously.
For treatment of different animal groups, vaccination was performed prior (5 days before surgical excision of the initial tumor node), after (5 days after surgical excision of the initial tumor node), and prior/after the surgical excision of the initial tumor node (the same terms).
Tumor metastization intensity was lower in vaccinated mice(down to 20-30%), than in the control group. The comparative analysis of vaccine antimetastatic activity using different surgical excisions of the initial tumor node schedules is presented in fig. 2 . 
